| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
RXST
RxSight
|
Aug 06, 2026 | HOLD |
Hold
+49.7% avg upside
13 analysts
|
$9.00
48.05% Upside
|
+0.0% | · |
|
ZBH
Zimmer Biomet Holdings
|
Aug 06, 2026 | HOLD |
Buy
+16.2% avg upside
38 analysts
|
$103.00
5.93% Upside
|
+0.0% | · |
|
MDT
Medtronic
|
Aug 05, 2026 | BUY |
Buy
+12.1% avg upside
38 analysts
|
$102.00
18.71% Upside
|
+0.0% | · |
|
PODD
Insulet
|
Aug 05, 2026 | HOLD |
Strong Buy
+61.2% avg upside
32 analysts
|
$144.00
3.46% Upside
|
-0.1% | · |
|
ATEC
Alphatec Holdings
|
Aug 05, 2026 | BUY |
Strong Buy
+80.0% avg upside
23 analysts
|
$14.00
52.10% Upside
|
-3.8% | · |
|
INSP
Inspire Medical Systems
|
Aug 04, 2026 | HOLD |
Buy
+42.8% avg upside
21 analysts
|
$56.00
4.85% Downside
|
· | · |
|
PEN
Penumbra
|
Aug 03, 2026 | HOLD |
Buy
+1.9% avg upside
23 analysts
|
$374.00
15.17% Upside
|
+0.8% | · |
|
JNJ
Johnson & Johnson
|
Aug 03, 2026 | BUY |
Strong Buy
-8.2% avg upside
39 analysts
|
$282.00
9.77% Upside
|
+1.0% | · |
|
MMSI
Merit Medical Systems
|
Jul 31, 2026 | HOLD |
Strong Buy
+13.0% avg upside
15 analysts
|
$83.00
5.34% Downside
|
+1.4% | · |
|
DXCM
Dexcom
|
Jul 31, 2026 | BUY |
Strong Buy
+26.2% avg upside
32 analysts
|
$90.00
8.46% Upside
|
-0.5% | · |
|
IART
Integra Lifesciences
|
Jul 30, 2026 | HOLD |
Buy
+151.5% avg upside
21 analysts
|
$18.00
5.28% Upside
|
-0.1% | · |
|
GEHC
GE Healthcare Technologies Inc
|
Jul 30, 2026 | BUY |
Strong Buy
+17.0% avg upside
22 analysts
|
$85.00
20.83% Upside
|
+1.3% | · |
|
GKOS
Glaukos
|
Jul 30, 2026 | BUY |
Strong Buy
-2.8% avg upside
21 analysts
|
$178.00
4.19% Upside
|
+4.9% | · |
|
CNMD
Conmed
|
Jul 30, 2026 | HOLD |
Hold
+31.2% avg upside
12 analysts
|
$46.00
7.66% Downside
|
+0.0% | · |
|
BSX
Boston Scientific
|
Jul 29, 2026 | HOLD |
Strong Buy
+38.2% avg upside
38 analysts
|
$50.00
1.44% Upside
|
+7.1% | · |
|
ISRG
Intuitive Surgical
|
Jul 23, 2026 | BUY |
Strong Buy
+28.2% avg upside
36 analysts
|
$487.00
30.23% Upside
|
+13.6% | · |
|
ABT
Abbott Laboratories
|
Jul 17, 2026 | BUY |
Strong Buy
+7.4% avg upside
36 analysts
|
$112.00
3.65% Upside
|
+7.2% | · |
|
KMTS
Kestra Medical Technologies Ltd.
|
Jul 15, 2026 | BUY |
Strong Buy
+11.4% avg upside
8 analysts
|
$28.00
10.73% Upside
|
-7.2% | · |
|
SYK
Stryker
|
Jul 08, 2026 | BUY |
Strong Buy
+9.2% avg upside
37 analysts
|
$418.00
23.81% Upside
|
+2.8% | · |
|
AVR
Anteris Technologies Global Corp.
|
Jun 15, 2026 | BUY |
Strong Buy
+76.9% avg upside
5 analysts
|
$16.00
91.47% Upside
|
-14.5% | · |
|
MMED
MiniMed Group, Inc.
|
Jun 08, 2026 | BUY |
Strong Buy
+18.4% avg upside
14 analysts
|
$26.00
41.21% Upside
|
+22.0% | · |
|
COO
Cooper Co
|
Jun 05, 2026 | HOLD |
Buy
+80.7% avg upside
21 analysts
|
$66.00
9.97% Downside
|
+10.0% | · |
|
TNDM
Tandem Diabetes Care
|
Jun 01, 2026 | BUY |
Buy
+72.2% avg upside
29 analysts
|
$27.00
43.73% Upside
|
+1.8% | · |
|
NPCE
NeuroPace
|
May 27, 2026 | BUY |
Strong Buy
+31.7% avg upside
13 analysts
|
$19.00
36.74% Upside
|
-18.5% | · |
|
SOLV
Solventum Corporation
|
May 22, 2026 | HOLD |
Strong Buy
+8.2% avg upside
16 analysts
|
$70.00
15.67% Downside
|
+8.0% | · |
|
HTFL
HeartFlow, Inc.
|
May 15, 2026 | BUY |
Strong Buy
+33.9% avg upside
9 analysts
|
$37.00
36.01% Upside
|
-4.0% | · |
|
ENOV
Enovis
|
May 08, 2026 | BUY |
Strong Buy
+151.8% avg upside
39 analysts
|
$40.00
52.02% Upside
|
+7.5% | · |
|
GMED
Globus Medical
|
May 08, 2026 | BUY |
Strong Buy
+14.6% avg upside
24 analysts
|
$103.00
27.11% Upside
|
+4.3% | · |
|
TFX
Teleflex
|
May 08, 2026 | HOLD |
Buy
+34.8% avg upside
20 analysts
|
$138.00
0.55% Downside
|
+5.6% | · |
|
NVCR
NovoCure
|
May 04, 2026 | HOLD |
Strong Buy
+213.2% avg upside
11 analysts
|
$17.00
8.39% Upside
|
-7.1% | · |
|
AXGN
AxoGen
|
Apr 29, 2026 | BUY |
Strong Buy
-21.3% avg upside
21 analysts
|
$48.00
8.22% Upside
|
+10.0% | · |
|
CH:ALC
Alcon
|
Feb 26, 2026 | BUY |
Buy
+25.4% avg upside
35 analysts
|
$78.20
38.60% Upside
|
-15.7% | · |
|
ITGR
Integer Holdings
|
Feb 20, 2026 | HOLD |
Buy
-18.4% avg upside
16 analysts
|
$84.00
33.43% Downside
|
+47.4% | · |
|
BLCO
Bausch + Lomb Corporation
|
Feb 19, 2026 | HOLD |
Buy
+21.2% avg upside
19 analysts
|
$18.00
9.99% Upside
|
-5.6% | · |
|
EW
Edwards Lifesciences
|
Feb 11, 2026 | BUY |
Strong Buy
+12.6% avg upside
34 analysts
|
$100.00
12.04% Upside
|
+12.6% | · |
|
BDX
Becton Dickinson
|
Feb 10, 2026 | HOLD |
Buy
+9.9% avg upside
25 analysts
|
$157.00
11.27% Downside
|
+3.8% | · |
|
RMD
Resmed
|
Jan 30, 2026 | HOLD |
Buy
+2.9% avg upside
27 analysts
|
$270.00
21.00% Upside
|
-12.8% | · |
|
BAX
Baxter International
|
Dec 12, 2025 | HOLD |
Buy
+21.7% avg upside
23 analysts
|
$19.00
29.61% Downside
|
+41.2% | · |
|
LUNG
Pulmonx
|
Nov 13, 2025 | HOLD |
Buy
+253.6% avg upside
9 analysts
|
$3.00
46.43% Upside
|
+28.9% | · |
|
HYPR
Hyperfine
|
Oct 21, 2025 | HOLD |
Strong Buy
+114.8% avg upside
7 analysts
|
— | -23.4% | · |
|
LNTH
Lantheus
|
Aug 02, 2018 | BUY |
Buy
-18.5% avg upside
21 analysts
|
$20.00
80.14% Downside
|
+68.5% | · |
|
NVS
Novartis
|
Jan 04, 2010 | BUY |
Hold
-13.4% avg upside
24 analysts
|
— | +15.1% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.